Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Some dibenzo compounds might help treat cancer with fewer side effects.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Inducing survivin in normal tissues can protect against radiation damage.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

TS-13 speeds up hair regrowth after chemotherapy.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Niosomal cetirizine shows promise for better alopecia treatment by targeting hair follicles effectively.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.